Top large-cap gainers for Dec. 15–19 were led by Rivian, Moderna, and BioMarin, rising on product/software updates, vaccine ...

Find out about the main events that have taken place on this day over the years.

Up to $54.3 million CEPI investment aims to help advance Moderna’s H5 pandemic influenza vaccine candidate to licensure Partnership strengthens global preparedness against a significant pandemic ...

Arrowhead Clinic Chiropractor Atlanta continues to address the urgent healthcare needs of auto accident victims through its ...

Stocks end the week little changed. Meanwhile, Rivian jumps 22%, while Nike falls.

The FDA has been rumored to be evaluating whether or not to place a black box warning on vaccines for COVID-19.

CAMBRIDGE, MA / ACCESS Newswire / December 17, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced it will present at the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12th at 7:30 p ...

This is likely our last weekly food news list for 2025, and there have been a surprising number of new developments in the ...

Moderna Inc. will get as much as $54.3 million for a late-stage trial of its bird flu vaccine in a sign of how outside groups ...

"As the ProFoundry Platform continues to reveal new proteins and to extend our understanding of human biology, we are in parallel scaling our organization both scientifically and organizationally," ...

The fresh capital provides another shot for Moderna's candidate against bird flu, which earlier this year lost its government ...